Pasar al contenido principal

ESTUDIO DEL MECANISMO DE TRANSREGENERACION ACTIVADO POR EL SISTEMA INMUNE A TRAVES DE LRH1: TERAPIA BASADA EN PROCESOS DE CICATRIZACION DE HERIDAS PARA TRATAR LA DIABETES T1

PID2021-123083NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD, M.P.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus

  • Gauthier, Benoit R.
  • Cobo-Vuilleumier, Nadia
  • López-Noriega, Livia
Extracellular vesicles (EVs), especially exosomes (50 to 150 nm), have been shown to play important roles in a wide range of physiological and pathological processes, including metabolic diseases such as Diabetes Mellitus (DM). In the last decade, several studies have demonstrated how EVs are involved in cell-to-cell communication. EVs are enriched in proteins, mRNAs and non-coding RNAs (miRNAs, long non-coding RNAs and circRNAS, among others) which are transferred to recipient cells and may have a profound impact in either their survival or functionality. Several studies have pointed out the contribution of exosomal miRNAs, such as miR-l42-3p and miR-26, in the development of Type 1 and Type 2 DM (T1DM and T2DM), respectively. In addition, some miRNA families such as miR-let7 and miR-29 found in exosomes have been associated with both types of diabetes, suggesting that they share common etiological features. The knowledge about the role of exosomal long non-coding RNAs in this group of diseases is more immature, but the exosomal lncRNA MALAT1 has been found to be elevated in the plasma of individuals with T2DM, while more than 169 lncRNAs were reported to be differentially expressed between healthy donors and people with T1DM. Here, we review the current knowledge about exosomal non-coding RNAs in DM and discuss their potential as novel biomarkers and possible therapeutic targets., The authors were/are funded by grants from Consejería de Salud, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010, December 2010 to BG, PI-0085-2013),; Consejería de Economía, Innovación y Ciencia, Junta de Andalucía (P10-CTS-6359 to BG); Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, cofounded by Fondos FEDER (PI10/00871, January 2011 and PI13/00593, January 2014 to BG); Ministerio de Economía y Competitividad, Plan Nacional(BFU2017-83588-P, January 2018 and PID2021-123083NB-I00, sept 2022 to BG); JuvenileDiabetes Research Foundation JDRF (17-2013-372, August 2013 and 2-SRA-2019-837-S-B, August2019 to BG); Special thanks to ALUSVI (Asociación Lucha y Sonríe por la Vida, Pilas), and the Fundacion DiabetesCERO for their unconditional financial support. LL-N is also funded by Procedimiento de selección de personal investigador Doctor con cargo a las ayudas concedidas mediante la Línea de Ayudas para Captación, Incorporación y Movilidad de Capital Humano de I+D+i (20804).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The PTGS2/COX2-PGE2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus

  • Martín-Vázquez, Eugenia
  • Cobo-Vuilleumier, Nadia
  • López-Noriega, Livia
  • Lorenzo, Petra Isabel
  • Gauthier, Benoit R.
Prostaglandins are lipid mediators involved in physiological processes, such as constriction or dilation of blood vessels, but also pathophysiological processes, which include inflammation, pain and fever. They are produced by almost all cell types in the organism by activation of Prostaglandin endoperoxide synthases/Cyclooxygenases. The inducible Prostaglandin Endoperoxide Synthase 2/Cyclooxygenase 2 (PTGS2/COX2) plays an important role in pathologies associated with inflammatory signaling. The main product derived from PTGS2/COX2 expression and activation is Prostaglandin E (PGE), which promotes a wide variety of tissue-specific effects, pending environmental inputs. One of the major sources of PGE are infiltrating inflammatory cells - the production of this molecule increases drastically in damaged tissues. Immune infiltration is a hallmark of type 1 diabetes mellitus, a multifactorial disease that leads to autoimmune-mediated pancreatic beta cell destruction. Controversial effects for the PTGS2/COX2-PGE signaling cascade in pancreatic islet cells subjected to diabetogenic conditions have been reported, allocating PGE as both, cause and consequence of inflammation. Herein, we review the main effects of this molecular pathway in a tissue-specific manner, with a special emphasis on beta cell mass protection/destruction and its potential role in the prevention or development of T1DM. We also discuss strategies to target this pathway for future therapies., The authors are supported by grants from the Consejería de Salud, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010 to B.R.G., PI-0085-2013 to P.I.L.), the Consejería de Economía, Innovación y Ciencia (P10.CTS.6359 to B.R.G and DOC_00652 to L.L.N.), the Ministerio de Ciencia E Innovación co-funded by Fondos FEDER (PI10/00871, PI13/00593 and BFU2017- 83588-P, PID2021-123083NB-I00 to B.R.G), Vencer el Cancer (B.R.G), DiabetesCero (B.R.G.) and the Juvenile Diabetes Research Foundation (17-2013-372, 2-SRA-2019-837-S-B, 3-SRA-2023-1307-S-B to B.R.G.). E.M.V. is recipient of a Fellowship from the Ministerio de Ciencia E Innovación co-funded by Fondos FEDER (PRE2018-084907).